Year |
Citation |
Score |
2022 |
Lee AJ, Huffmyer JL, Thiele EL, Zeitlin PL, Chatterjee D. The Changing Face of Cystic Fibrosis: An Update for Anesthesiologists. Anesthesia and Analgesia. PMID 35020677 DOI: 10.1213/ANE.0000000000005856 |
0.333 |
|
2010 |
Ferkol T, Zeitlin P, Abman S, Blaisdell CJ, O'Brodovich H. NHLBI training workshop report: The vanishing pediatric pulmonary investigator and recommendations for recovery. Pediatric Pulmonology. 45: 25-33. PMID 20025052 DOI: 10.1002/Ppul.21155 |
0.311 |
|
2010 |
Kovell L, Ishman S, Zeitlin P, Boss E. Pediatric Cystic Fibrosis and Sinusitis Otolaryngology–Head and Neck Surgery. 143: P115-P116. DOI: 10.1016/J.Otohns.2010.06.212 |
0.38 |
|
2009 |
Ferkol T, Zeitlin P, Abman S, Blaisdell CJ, O'Brodovich H. NHLBI training workshop report: the vanishing pediatric pulmonary investigator and recommendations for recovery. Lung. 187: 367-74. PMID 19806399 DOI: 10.1007/S00408-009-9184-0 |
0.313 |
|
2007 |
Moss RB, Milla C, Colombo J, Accurso F, Zeitlin PL, Clancy JP, Spencer LT, Pilewski J, Waltz DA, Dorkin HL, Ferkol T, Pian M, Ramsey B, Carter BJ, Martin DB, et al. Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial. Human Gene Therapy. 18: 726-32. PMID 17685853 DOI: 10.1089/Hum.2007.022 |
0.306 |
|
2007 |
Gibson RL, Emerson J, Mayer-Hamblett N, Burns JL, McNamara S, Accurso FJ, Konstan MW, Chatfield BA, Retsch-Bogart G, Waltz DA, Acton J, Zeitlin P, Hiatt P, Moss R, Williams J, et al. Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis. Pediatric Pulmonology. 42: 610-23. PMID 17534969 DOI: 10.1002/Ppul.20625 |
0.305 |
|
2007 |
Clancy JP, Rowe SM, Bebok Z, Aitken ML, Gibson R, Zeitlin P, Berclaz P, Moss R, Knowles MR, Oster RA, Mayer-Hamblett N, Ramsey B. No detectable improvements in cystic fibrosis transmembrane conductance regulator by nasal aminoglycosides in patients with cystic fibrosis with stop mutations. American Journal of Respiratory Cell and Molecular Biology. 37: 57-66. PMID 17347447 DOI: 10.1165/Rcmb.2006-0173Oc |
0.371 |
|
2004 |
Zeitlin P. Can curcumin cure cystic fibrosis? The New England Journal of Medicine. 351: 606-8. PMID 15295056 DOI: 10.1056/Nejmcibr041584 |
0.329 |
|
2003 |
Flotte TR, Zeitlin PL, Reynolds TC, Heald AE, Pedersen P, Beck S, Conrad CK, Brass-Ernst L, Humphries M, Sullivan K, Wetzel R, Taylor G, Carter BJ, Guggino WB. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. Human Gene Therapy. 14: 1079-88. PMID 12885347 DOI: 10.1089/104303403322124792 |
0.309 |
|
2001 |
Noone PG, Hamblett N, Accurso F, Aitken ML, Boyle M, Dovey M, Gibson R, Johnson C, Kellerman D, Konstan MW, Milgram L, Mundahl J, Retsch-Bogort G, Rodman D, Williams-Warren J, ... ... Zeitlin P, et al. Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: results of a phase I multi-center study. Pediatric Pulmonology. 32: 122-8. PMID 11477729 DOI: 10.1002/Ppul.1098 |
0.324 |
|
1998 |
Rosenstein BJ, Zeitlin PL. Cystic fibrosis. Lancet (London, England). 351: 277-82. PMID 9457113 DOI: 10.1016/S0140-6736(97)09174-5 |
0.301 |
|
1997 |
Rubenstein RC, McVeigh U, Flotte TR, Guggino WB, Zeitlin PL. CFTR gene transduction in neonatal rabbits using an adeno-associated virus (AAV) vector. Gene Therapy. 4: 384-92. PMID 9274714 DOI: 10.1038/Sj.Gt.3300417 |
0.34 |
|
Show low-probability matches. |